Toggle navigation
Home
Search
Services
Blog
Contact
About
New Drugs to Prevent Ischemia Reperfusion Injury
Elford, Howard Lee
Molecules for Health, Inc., Richmond, VA, United States
Search 13 grants from Howard Elford
Search grants from Molecules for Health, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Postdoctoral training in genomic medicine research
Predicting Classes of Functional Trajectories: Malleable Risk Factors
Determinants of Resilience: Mental Health, Maltreatment and Adaptive Behavior
p21 As an Inducer of Disease-Associated gene expression
INIA: Neurohistology
Recently added grants:
Exploiting the distinct genomics and signaling of colorectal cancers to effectively target ERK
Cellular Epigenetic Heterogeneity as a Predeterminant of Malignant Transformation Potential
Childhood Cancer Survivor Study
Bridging the gap between GWAS and mechanism in JIA
1/2 Leveraging electronic health records for pharmacogenomics of psychiatric disorders
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44HL044250-03
Application #
2221403
Study Section
Special Emphasis Panel (SSS (B6))
Project Start
1990-09-01
Project End
1998-03-31
Budget Start
1994-08-01
Budget End
1998-03-31
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Institution
Name
Molecules for Health, Inc.
Department
Type
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23219
Related projects
NIH 1994
R44 HL
New Drugs to Prevent Ischemia Reperfusion Injury
Elford, Howard Lee / Molecules for Health, Inc.
NIH 1993
R44 HL
New Drugs to Prevent Ischemia Reperfusion Injury
Elford, Howard Lee / Molecules for Health, Inc.
Comments
Be the first to comment on Howard Elford's grant